Date
2020Journal
Critical care (London, England)Publisher
Springer NatureType
Article
Metadata
Show full item recordIdentifier to cite or link to this item
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85083071494&doi=10.1186%2fs13054-020-02862-1&partnerID=40&md5=4af3cab6aecdc877312a48c7bea34516; http://hdl.handle.net/10713/12618ae974a485f413a2113503eed53cd6c53
10.1186/s13054-020-02862-1
Scopus Count
Related articles
- COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?
- Authors: Aleksova A, Ferro F, Gagno G, Cappelletto C, Santon D, Rossi M, Ippolito G, Zumla A, Beltrami AP, Sinagra G
- Issue date: 2020 Oct
- Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and SARS-CoV-2.
- Authors: Young MJ, Clyne CD, Chapman KE
- Issue date: 2020 Nov
- Covid-19: the renin-angiotensin system imbalance hypothesis.
- Authors: Lanza K, Perez LG, Costa LB, Cordeiro TM, Palmeira VA, Ribeiro VT, Simões E Silva AC
- Issue date: 2020 Jun 12
- RAAS blockers in hypertension posing a higher risk toward the COVID-19.
- Authors: Singh Y, Gupta G, Satija S, Negi P, Chellappan DK, Dua K
- Issue date: 2020 Jul
- [ACE2 and coronavirus - a question of balance and dynamics?]
- Authors: Lundström A, Sandén P
- Issue date: 2020 Apr 17